Autoreactive Iga Antibodies against the Pancreatic Major Glycoprotein 2 are Associated with Primary Sclerosing Cholangitis and Related Biliary Tract Cancer
Sebastian Torben Jendrek(University of Lübeck), Christian Sina(Khalifa University of Science and Technology), Peter Schemmer(Heidelberg University), Evaggelia Liaskou(Cancer Research UK Clinical Trials Unit), Klaus Fellermann(Apple (Israel)), Mette Vesterhus(Deaconess Hospital), Stefanie Derer(Universitäres Kinderwunschzentrum Lübeck), Lars Komorowski(Euroimmun Medizinische Labordiagnostika (Germany)), Tobias Korf(University of Lübeck), Fabrizio Bar(Ospedale San Luigi Gonzaga), Teresa Schroder, Thomas Nitzsche(Euroimmun Medizinische Labordiagnostika (Germany)), Marc Ehlers(University Hospital Schleswig-Holstein), Christoph M. Hammers(University of Regensburg), T.H. Karlsen, Johannes R. Hov(Oslo University Hospital), Swantje Mindorf(Mayo Clinic), Maike Anna Michaels(University of Lübeck), H. Lehnert(University Hospital Schleswig-Holstein), K.H. Weiss(Hôpital Maisonneuve-Rosemont), D Gotthardt
Cited by 1
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566